Lurbinectedin is a chemotherapy drug used for the treatment of certain types of cancer. According to the sources provided, there are potential long-term side effects associated with the use of Lurbinectedin.

The first source [1] provides information about the patent status of Lurbinectedin. It does not provide any information about the long-term effects of the drug.

The second source [2] is from the Mayo Clinic and lists several potential side effects of Lurbinectedin. While most of these side effects are temporary and resolve after treatment, there are some potential long-term effects that may occur. These include damage to the heart, liver, or kidneys, which can lead to long-term health problems. Additionally, Lurbinectedin can cause nerve damage, which may be permanent.

The third source [3] is the official website for Zepzelca, a brand name for Lurbinectedin. The website lists similar potential side effects to those listed by the Mayo Clinic, including heart, liver, and kidney damage, as well as nerve damage.

In conclusion, while Lurbinectedin is an effective chemotherapy drug for certain types of cancer, there are potential long-term side effects associated with its use. These include damage to the heart, liver, and kidneys, as well as nerve damage. It is important for patients to discuss these potential side effects with their healthcare provider before starting treatment with Lurbinectedin.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/LURBINECTEDIN
[2] https://www.mayoclinic.org/drugs-supplements/lurbinectedin-intravenous-route/side-effects/drg-20490804
[3] https://www.zepzelca.com/zepzelca-side-effects/